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We estimated the total number of human alveolar echi-
nococcosis cases in Germany from 2003 through 2005 us-
ing the multiple source capture-recapture method. We found 
a 3-fold higher incidence of the disease than that shown by 
national surveillance data. We propose a revision of the re-
porting system to increase case ascertainment. 
H
uman alveolar echinococcosis (AE), caused by the 
metacestode stage of the fox tapeworm Echinococ-
cus multilocularis, is a rare zoonosis in Germany, mainly 
occurring in the south (1). The parasite predominantly de-
velops in the liver of the human host, where the inﬁ  ltrat-
ing growth can cause serious damage (2). Untreated AE 
has a very high fatality rate (3); when the patient survives, 
the cost of life-long treatment is substantial, projected at 
US $300,000 per patient (4). E. multilocularis infection is 
highly endemic among foxes in Germany, and studies in-
dicate that the parasite’s geographic range has widened in 
recent years (5,6). Growing fox populations in Europe, es-
pecially in urban zones, have drawn attention to a potential 
increased risk for humans (7–9).
In 2001, AE reporting became mandatory in Germany 
(10). Diagnosis of echinococcosis by serologic testing and 
histopathologic examination is reportable to the Robert 
Koch Institute (RKI) by microbiologic laboratories and pa-
thologists, respectively. However, reports rarely come from 
pathologists. Referring physicians must provide additional 
diagnostic data (e.g., imaging ﬁ  ndings and clinical infor-
mation to conﬁ  rm serologically diagnosed AE) but are not 
required to report cases independent of the laboratory diag-
nosis. Additionally, clinicians voluntarily report AE case-
patients with active lesions to the European Echinococcosis 
Registry (EER) associated with the clinical referral center 
for AE in Ulm, Germany (11).
We conducted a 3-source capture–recapture analysis 
to generate an estimate of the true number of AE cases in 
Germany from 2003 through 2005. On the basis of this esti-
mate, we assessed the sensitivity of the national surveillance 
system.
The Study
The capture–recapture method estimates unascertained 
cases by comparing data from >2 different sources. It re-
quires that persons have a correct diagnosis and equal prob-
ability of inclusion (catchability) and that the study popula-
tion be closed. If only 2 sources are used, these should be 
independent (12). 
We used 3 data sources: RKI, EER, and a pathologists’ 
survey (PAS) conducted in June 2006 among all registered 
pathology laboratories in Germany (≈525). Pathologists 
were requested to complete a questionnaire reporting all 
echinococcosis cases diagnosed from 2003 through 2005 
to RKI.
We deﬁ  ned  conﬁ   rmed AE case-patients as persons 
with positive results of histopathologic examination or with 
liver lesion showing typical morphologic features, identi-
ﬁ  ed by imaging techniques. Only case-patients with a ﬁ  rst 
diagnosis from 2003 through 2005 were included. Because 
reporting of AE is anonymous, we used 3 proxy matching 
identiﬁ  ers. Matching criteria were identical: 1) year and 
month of birth, 2) sex, and 3) year and month of diagnosis 
(±6 months to allow for time variability of different diag-
nostic methods). For case-patients for whom month of birth 
or month of diagnosis was missing in >1 source, the ﬁ  rst 
3 digits of the case-patient’s postal code or the referring 
physician’s postal code had to be identical in addition to 
the above criteria.
The distribution of matched and unmatched observed 
cases by source is displayed in a Venn diagram (Figure). 
To predict the frequency of unascertained cases, we con-
structed log-linear models. Each model included a variable 
for each source and up to 3 possible interaction variables 
between sources. The saturated model included all 3 inter-
actions, whereas the independent model assumed no inter-
actions (13).
We selected the ﬁ  nal model using Akaike’s Informa-
tion Criterion (AIC), which indicates how well a model 
ﬁ  ts the data, considering the number of variables included. 
Small values of AIC correspond to a better adapted model 
(12). Ninety-ﬁ  ve percent goodness-of-ﬁ  t conﬁ  dence inter-
vals (95% CI) were calculated based on the likelihood ratio, 
to allow asymmetric intervals and avoid underestimation of 
the upper and lower limits (14). 
The sensitivity of RKI data was estimated by dividing 
the number of cases reported to RKI by the total number of 
cases (N) from the selected model. Analysis was performed 
with Stata 9.0 (StataCorp, College Station, TX, USA) (15).
A total of 60 conﬁ  rmed cases were reported to RKI; 
EER registered 59. The response rate for PAS was 64% 
(335 of 525 surveyed). Pathologists reported 49 AE cases 
in the survey, of which 25 were the ﬁ  rst diagnosis, 5 were 
previously diagnosed, and 19 had no date of ﬁ  rst diagnosis. 
Table 1 summarizes case-patient characteristics by source. 
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*Robert Koch Institute, Berlin, Germany; and †European Echi-
nococcosis Registry, Ulm, Germany From 2003 through 2005, 114 conﬁ  rmed cases were re-
corded by the combined sources, of which 28 could be 
matched (Figure).
Log-linear estimates for N ranged from 184 to 399 
cases (Table 2). Model 5, with the single interaction term 
between RKI and PAS, was selected as the best ﬁ  tting 
(AIC =   –3.33) model. According to this model, 70 cases 
were missed, yielding 184 cases (95% CI 150–242) over 3 
years. This corresponds to 61 cases (95% CI 50–81) annu-
ally, with an incidence rate of 0.07/100,000 persons. The 
lower estimate in model 5, compared with that of the inde-
pendent model, suggested a negative dependence between 
RKI and PAS reports. Sensitivity of RKI was 33% (95% 
CI 25%–40%). 
Conclusions
We estimated that the national surveillance system 
failed to detect 67% of AE cases in Germany over 3 years. 
Underreporting may occur for several reasons. Pathologists 
might be unaware of their obligation to report. Further-
more, reports almost exclusively come from microbiologic 
laboratories, and, consequently, case-patients who do not 
undergo serologic testing, or who have seronegative re-
sults, are likely to be missed. Finally, the reporting proce-
dure is arduous because forms are detailed and must be ﬁ  rst 
ordered from RKI. 
Capture–recapture estimates can be biased if the under-
lying assumptions are violated. Because case identiﬁ  cation 
was based on several variables, the potential for mismatch-
ing was considered small. However, the lenient criteria may 
have led to overmatching. Including more or fewer matching 
criteria had only a small effect on the estimate.
In the ﬁ  nal models, we excluded cases reported through 
PAS when ﬁ  rst-diagnosis status was unknown. Log-linear 
analysis that included these cases resulted in a higher es-
timate; therefore, we are conﬁ  dent that the exclusion did 
not overestimate the number of cases. Varying catchabil-
ity can be addressed by stratiﬁ  cation. Although the sources 
differed with regard to geographic distribution, we consid-
ered stratiﬁ  ed analysis inappropriate due to missing postal 
codes for several case-patients, zero values in 1 stratum, 
and small numbers in general, which would increase the 
uncertainty around our estimate. 
AE is not equally distributed in Germany, and the dif-
ferent geographic distribution of cases reported by PAS 
compared with RKI and EER indicated that PAS had missed 
case-patients mainly from the south. The number of histo-
pathologically diagnosed cases was therefore likely underes-
timated. The importance of this for the estimated true number 
of AE case-patients presented here cannot be ascertained.
The negative dependence between RKI and PAS can 
be explained by diagnostic practices. Unpublished data 
from EER suggest that histopathologically diagnosed cases 
are less likely to have serologic test results than those with-
out histopathologic examination. If a case-patient has had 
a histopathologic examination with positive results early 
in the diagnostic decision-making process, additional se-
rologic testing is unnecessary, which reduces the chance 
of these case-patients being reported to RKI. Reporting to 
EER is independent of serologic testing, which could ex-
plain the greater overlap between EER and PAS than be-
tween RKI and PAS.
Despite the limitations, the study did demonstrate poor 
reporting of AE. To improve the national surveillance sys-
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Table 1. Main characteristics of human alveolar echinococcosis case-patients by source, Germany, 2003–2005* 
Characteristic RKI (n = 60)  EER (n = 59)  PAS (n = 25) 
Median age, y (range)  52 (15–92)  53 (17–81)  52 (18–81) 
Female sex, no. (%)   32 (53)  29 (49)  14 (56) 
Residence south Germany, no. (%)†  35 (76)‡  46 (77)  10 (53)§ 
*RKI, Robert Koch Institute; EER, European Echinococcosis Registry; PAS, pathologists’ survey. Data as of March 2007. 
†Case-patients for whom the 3 first digits of the residential postal code was >600.
‡Data available for 46 case-patients. 
§Data available for 19 case-patients. 
Table 2.  Log linear estimates of the total number of alveolar echinococcosis cases, Germany, 2003–2005* 
Models† df AIC xN 95% CI for N
Saturated: Interaction (RKI, EER) and (RKI, PAS) and (EER, PAS)  0 0.00 174 288 129–2020
Interaction (RKI, EER) and (RKI, PAS)  1 –1.49 83 197 143–358
Interaction (RKI, PAS) and (EER, PAS)  1 –1.33 70 184 148–253
Interaction (RKI, EER) and (EER, PAS)   1 –1.66 285 399 189–1961
Interaction (RKI, PAS)  2 –3.33 70 184 150–242
Interaction (RKI, EER)   2 –1.57 134 248 171–430
Interaction (EER, PAS)  2 –0.08 93 207 163–287
Independent (no interactions)  3 –1.94 89 203 163–268
*RKI, Robert Koch Institute; EER, European Echinococcosis Registry; PAS, pathologists’ survey; df, degrees of freedom; AIC, Akaike Information 
Criterion (measures how well the model fits the data [small values indicate a better fit]); x, estimate of unascertained cases; N, estimate of total number of 
cases (total number of observed cases + x); CI, goodness-of-fit–based confidence interval.  
†Each model includes all first-order terms. The first model (saturated) adjusts for dependencies between all 3 source pairs; the second model adjusts for 
possible dependencies between RKI and EER, and between RKI and PAS, etc. Human Alveolar Echinococcosis, Germany
tem, the focus of reporting should be shifted from microbi-
ologic laboratories and pathologists to referring physicians, 
who usually collate the various diagnostic results. 
Sustaining a surveillance system for AE in Germany 
is a major challenge because the disease is rare. However, 
a recent report on increasing human AE in neighboring 
Switzerland (8) underlines the importance of an effective 
surveillance system with adequate sensitivity to detect 
changes in disease incidence in order to guide strategies for 
prevention and control.
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Figure. Venn diagram illustrating the distribution of conﬁ  rmed ﬁ  rst-
diagnosis human alveolar echinococcosis cases from 2003 through 
2005 in Germany by source and number of matches between 
sources. Data as of March 2007. RKI, Robert Koch Institute; EER, 
European Echinococcosis Registry; PAS, pathologists’ survey.
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